Vitamin D supplementation to reduce depression in adults: Meta-analysis of randomized controlled trials

Nutrition

Volumn 31, Issue 3, 2015, Pages 421-429

  Gowda, Usha ^a   Mutowo, Mutsa P ^a   Smith, Ben J ^a   Wluka, Anita E ^b   Renzaho, Andre M N ^a,c,d  

^a MONASH UNIVERSITY   (Australia)

^b Centre of Cardiovascular Research Education in Therapeutics School of Public Health and Preventive Medicine   (Australia)

^c BURNET INSTITUTE   (Australia)

^d UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

25 Hydroxyvitamin D3; Brain function; Depressive symptoms; Placebo; Pooled effect

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; COLECALCIFEROL; PLACEBO; VITAMIN D; VITAMIN;

ADULT; DEPRESSION; DRUG DOSE COMPARISON; DRUG EFFICACY; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEASONAL AFFECTIVE DISORDER; TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; DEPRESSIVE DISORDER; DIET SUPPLEMENTATION; VITAMIN D DEFICIENCY;

ADULT; DEPRESSION; DEPRESSIVE DISORDER; DIETARY SUPPLEMENTS; HUMANS; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84923044822     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2014.06.017     Document Type: Review

References (51)

1. Williams R.F., Doessel D.P. The Australian mental health system: an economic overview and some research issues. Int J Men Healthy Syst 2008, 2:4.
2. Prince M., Patel V., Saxena S., Maj M., Maselko J., Phillips M. No health without mental health. Lancet Infect Dis 2007, 370:959-977.
3. World Health Organization World Health Mental Day, depression: a global crisis 2012, World Federation for Mental Health, Occoquan, VA.
4. Mozaffari-Khosravi H., Nabizade L., Yassini-Ardakani S., Hadinedoushan H., Barzegar K. The effect of 2 different single injections of high dose of vitamin D on improving the depresssed patients with vitamin D deficiency. J Clin Psychopharmacol 2013, 33:378-385.
5. Eyles D., Smith S., Kinobe R., Hewison M., McGrath J.J. Distribution of the vitamin D receptor and 1 alpha hydroxylase in human brain. J Clin Neurosci 2005, 29:21-30.
6. Bertone-Johnson E.R. Vitamin D and the occurrence of depression: causal association or circumstantial evidence?. Nutr Rev 2009, 67:481-492.
7. Garcion E., Wion-Barbot N., Montero-Menei C.N., Berger F., Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 2002, 13:100-105.
8. Fernandez de Abreu D., Eyles D., Feron F., Vitamin D. a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology 2009, 34:S265-S277.
9. Veith R., Kimball S., Hu A., Walfish P.G. Randomized comparison of the effects of the vitamin D3 capsule adequate intakes versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutr J 2004, 3:8.
10. Bertone-Johnson E.R., Hankinson S.E., Bendich A., Johnson S.R., Willett W.C., Manson J.E. Calcium and vitamin D intake and risk of incident premenstrual syndrome. Arch Intern Med 2005, 165:1246-1252.
11. Armstrong D., Meenagh G.K., Bickle I., Lee A.S., Curran E.S., Finch M.B. Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin Rheumatol 2007, 26:551-554.
12. Lansdowne A.T.G., Provost S.C. Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology 1998, 135:319-323.
13. Hoogendijk W.J., Lips P., Dik M.G., Deeg D.J., Beekman A.T., Penninx B.W. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry 2008, 65:508-512.
14. Zhao G., Ford E.S., Li C., Balluz L.S. No associations between serum concentrations of 25-hydroxyvitamin D and parathyroid hormone and depression among US adults. Br J Nutr 2010, 104:1696-1702.
15. Anglin R.E., Samaan Z., Walter S.D., McDonald S.D. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry 2013, 202:100-107.
16. Shaffer J.A., Edmondson D., Wasson L.T., Falzon L., Homma K., Ezeokoli N., et al. Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials. Psychosom Med 2014, 76:190-196.
17. Li G., Mbuagbaw L., Samaan Z., Falavigna M., Zhang S., Adachi J.D., et al. Efficacy of vitamin D supplementation in depression in adults: a systematic review. J Clin Endocrinol Metab 2014, 99:757-767.
18. Liberati A., Altman A., Tetzlaff J., Mulrow C., Gotzsche P., Ioannidia J., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions:explanation and elaboration. BMJ 2009, 339:b2700.
19. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds J.M., Gavaghan D., et al. Assessing the quality of reports of randomised clinical trials: Is blinding necessary?. Control Clin Trials 1996, 17:1-12.
20. Juni P., Altman D., Egger M. Assessing the quality of controlled clinical trials. Br Med J 2001, 323:42-46.
21. Higgins J, Green S. Cochrane handbook for systematic review of interventions; Cochrane Collaboration 2011. Updated March 2011. 5.1.0. Available at: Accessed September 10, 2013. http://handbook.cochrane.org.
22. Hozo S.P., Djulbegovic B., Hozo I. Estimating the mean and variance from themedian, range and the size of a sample. BMC Med Res Methodol 2005, 5:1-10.
23. Sanders K.M., Stuart A.L., Williamson E.J., Jacka F.N., Dodd S., Nicholson G., et al. Annual high-dose vitamin D3 and mental well-being: randomised controlled trial. Br J Psychiatry 2011, 198:357-364.
24. Arvold D.S., Odean M.J., Dornfeld M.P., Regal R.R., Arvold J.G., Karwoski G.C., et al. Correlation of symptoms with vitamin D deficiency and symptom response to cholecalciferol treatment: a randomized controlled trial. Endocr Pract 2009, 15:203-212.
25. Nowson C.A., McGrath J.J., Ebeling P.R., Haikerwal A., Daly R.M., Sanders K.M., et al. Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust 2012, 196:1-11.
26. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011, 96:1911-1930.
27. Ross A.C., Taylor C.L., Yaktine A.L., Del Valle H.B. Dietary reference intakes for calcium and vitamin D 2009, Committee to Review Dietary Reference Intakes for Vitamin D and Calcium Food and Nutrition Board, The National Academies Press, Washington DC.
28. Jorde R., Sneve M., Figenschau Y., Svartberg J., Waterloo K. Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med 2008, 264:599-609.
29. Bertone-Johnson E.R., Powers S.I., Spangler L., Larson J., Michael Y.L., Millen A.E., et al. Vitamin D supplementation and depression in the women's health initiative calcium and vitamin D trial. Am J Epidemiol 2012, 176:1-13.
30. Khoraminya N., Tehrani-Doost M., Jazayeri S., Hosseini A., Djazayery A. Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder. Aust NZJ Psych 2013, 47:271-275.
31. Yalamanchili V., Gallagher J.C. Treatment with hormone therapy and calcitriol did not affect depression in older postmenopausal women: no interaction with estrogen and vitamin D receptor genotype polymorphisms. Menopause 2012, 19:697-703.
32. Hogie-Lorenzen T.L. The relationship between depression levels and vitamin D status among older adults in Eastern South Dakota. Unpublished master's thesis 2003, South Dakota State University, Madison, SD.
33. Publication bias. The Cochrane collaboration open learning material. Available at: Accessed May 5,2014. http://www.cochrane-net.org/openlearning.
34. Dean A.J., Bellgrove M.A., Hall T., Phan W.M.J., Eyles D.W., Kvaskoff D., et al. Effects of vitamin D supplementation on cognitive and emotional functioning in young adults-a randomised controlled trial. PLoS One 2011, 6:e25966.
35. Kjaergaard M., Waterloo K., Wang C.E., Almas B., Figenschau Y., Hutchinson M.S., et al. Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: Nnested case-control study and randomised clinical trial. Br J Psychiatry 2012, 201:360-368.
36. Milaneschi Y., Shardell M., Corsi A.M., Vazzana R., Bandinelli S., Guralnik J.M., et al. Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. J Clin Endocrinol Metab 2010, 95:3225-3233.
37. May H.T., Bair T.L., Lappe D.L., Anderson J.L., Horne B.D., Carlquist J.F., et al. Association of vitamin D levels with incident depression among a general cardiovascular population. Am Heart J 2010, 159:1037-1043.
38. Ju S.Y., Lee Y.J., Jeong S.N. Serum 25-hydroxyvitamin D levels and the risk of depression: a systematic review and meta-analysis. J Nutr Health Aging 2013, 17:447-455.
39. Humble M.B. Vitamin D, light and mental health. J Photochem Photobiol B, Biol 2010, 101:142-149.
40. McCann J.C., Ames B.N. Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction?. FASEB J 2008, 22:982-1001.
41. Beck A.T., Steer R.A., Garbin M.G. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 1988, 8:77-100.
42. Yesavage J.A., Brink T.L., Rose T.L., Lum O., Huang V., Adey M.B., et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1983, 17:37-49.
43. Goldberg D.P., Gater R., Sartorius N., Ustun B., Piccinelli M., Gureje O., et al. The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychosom Med 1997, 27:191-197.
44. Trajkovic G., Starcevic V., Latas M., Lestarevic M., Ille T., Bukumiric Z., et al. Reliability of the Hamilton rating Scale for Depression: a meta-analysis over a period of 49 y. Psychiatry Res 2011, 189:1-9.
45. Burnam M.A., Wells K.B., Leake B., Lansverk J. Development of a brief screening instrument for detecting depressive disorders. Med Care 1988, 26:775-789.
46. Bennett R. The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 2005, 23:154-162.
47. Watson D., Clark L.A. Development and validation of brief measures of positive and negative affect: The PANAS scales. J Pers Soc Psychol 1988, 54:1063-1070.
48. Penckofer S., Koube J., Byran M., Ferrans C.E. Vitamin D and depression: where is all the sunshine?. Issues Ment Health Nurs 2010, 31:385-393.
49. Lemstra M., Neudorf C., DÁrcy C., Kunst A., Warren L.M., Bennett N.R. A systematic review of depressed mood and anxiety by SES in youth ages 10 to 15 y. CJ Pub Health 2008, 99:125-129.
50. Lustman P., Penckofer S., Clouse R. Recent advances in understanding depression in adults with diabetes. Curr Diab Rep 2008, 7:114-122.
51. Strine T.W., Mokdad A.H., Dube S.R., Balluz L.S., Gonzalez O., Berry J.T., et al. The association of depression and anxiety with obesity and unhealthy behaviors across community dwelling US adults. Gen Hosp Psychiatry 2008, 30:127-137.